Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of STEAP2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse |
| Host species | Rabbit |
| Applications | WB-Ti,IHC-P |
More info about STEAP2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB13007 |
| Product name: | STEAP2 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of STEAP2. |
| Gene id: | 261729 |
| Gene name: | STEAP2 |
| Gene alias: | IPCA1|PCANAP1|PUMPCn|STAMP1|STMP |
| Gene description: | six transmembrane epithelial antigen of the prostate 2 |
| Immunogen: | A synthetic peptide corresponding to C-terminus 16 amino acids of human STEAP2. |
| Protein accession: | Q8NFT2 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1-2 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.02% sodium azide) |
| Storage instruction: | Store at 4°C for three months. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse |
| Application image: |  |
| Application image note: | Immunohistochemistry of STEAP2 in human colon tissue with STEAP2 polyclonal antibody (Cat # PAB13007) at 2.5 ug/mL . |
| Applications: | WB-Ti,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate.Porkka KP, Helenius MA, Visakorpi T. Lab Invest. 2002 Nov;82(11):1573-82. |